Goldman Sachs has upgraded Bunzl plc (LON:BNZL) from Sell to Neutral, pointing to a more balanced risk/reward profile after a steep share price drop this year. The bank set a 12-month price target of 2,510p, implying about 5% upside from current levels, according to Reuters.Bunzl, the British distribution and outsourcing company, has seen its stock fall roughly 30% in 2025, weighed down by an April profit warning that lowered growth and margin expectations for next year. That warning was tied in part to wea ...

By Louise Rasmussen, Jacob Gronholt-Pedersen and Maggie Fick COPENHAGEN (Reuters) - Novo Nordisk, the maker of blockbuster weight-loss drug Wegovy, said on Wednesday it will cut 9,000 jobs in a bid to reignite growth and fend off intense competition from U.S. rival Eli Lilly and a wave of compounded copycat drugs. The restructuring, including the largest layoff in Denmark's history, is expected to save 8 billion Danish crowns ($1.25 billion) annually and comes as Novo Nordisk is battling to revive its fo ...